Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

13.1K
The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...
13.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting adherence of imatinib in gastrointestinal stromal tumor-rise of the machines!

Journal of gastrointestinal oncology·2026
Same author

Fully human anti-FOLR1 T-cell engager demonstrates potent activity in CBFA2T3::GLIS2 acute megakaryoblastic leukemia.

Blood neoplasia·2026
Same author

Regionally anchored, globally connected: lessons from the Pacific on the cancer workforce crisis.

The Lancet. Oncology·2026
Same author

VoxelCoder: Classification of human cellular phenotypes via autoencoder batch alignment and hyperdimensional representation of cytometry data.

Patterns (New York, N.Y.)·2026
Same author

Oncological Outcomes after Elective and Emergency Resection of Small Intestinal Neuroendocrine Tumours.

Journal of gastrointestinal cancer·2026
Same author

Cancer classification with radiomics in controlled preclinical models.

Scientific reports·2026

Related Experiment Video

Updated: Jul 18, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.0K

Identifying cancer-associated leukocyte profiles using high-resolution flow cytometry screening and machine learning.

David A Simon Davis1, Melissa Ritchie1, Dillon Hammill2

  • 1Irradiation Immunity Interaction Lab, Australian National University, Canberra, ACT, Australia.

Frontiers in Immunology
|August 21, 2023
PubMed
Summary

Blood immune cell signatures, particularly monocyte subsets, can serve as biomarkers for cancer detection and progression. Machine learning models trained on these signatures show promise for identifying cancer presence and type.

Keywords:
biomarkerscancerflow cytometryimmunologyleukocytesmachine learning

More Related Videos

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

227
Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
09:44

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Published on: September 5, 2019

7.3K

Related Experiment Videos

Last Updated: Jul 18, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.0K
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

227
Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
09:44

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Published on: September 5, 2019

7.3K

Area of Science:

  • Immunology
  • Oncology
  • Bioinformatics

Background:

  • Machine learning (ML) aids clinical decision-making by modeling complex data.
  • Identifying novel biomarkers can enhance ML effectiveness in cancer detection.
  • Cancer-related immune cell signatures are a promising area for biomarker discovery.

Purpose of the Study:

  • To investigate blood immune cell signatures as potential biomarkers for cancer progression.
  • To develop and test a pipeline for identifying cancer-specific leukocyte biomarkers.

Main Methods:

  • Developed a multiparameter cell-surface marker screening pipeline.
  • Utilized flow cytometry for high-resolution leukocyte population profiling.
  • Employed CATboost machine learning models for cancer prediction.

Main Results:

  • Identified a signature of blood leukocyte subsets, including monocyte subsets.
  • Demonstrated that these signatures can predict the presence and type of cancer in murine models.
  • Successfully trained ML models to correlate immune cell profiles with cancer status.

Conclusions:

  • Blood immune cell signatures show potential as robust biomarkers for cancer detection and characterization.
  • The developed screening pipeline can be adapted for use with human cancer patient blood samples.
  • This approach offers a novel strategy for enhancing ML-based cancer diagnostics.